Allergan plc (AGN) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Allergan plc (AGN) over the last 10 years. The current PE ratio for Allergan plc as of February 16, 2018 is 10.02.
|Medical||Medical - Generic Drugs||$54.186B||$15.941B|
|Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.|